ARCHIVES

NCI Advisors Approve New Grant Programs Worth $100 Million

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Clearinghouse Group Selects 10 More Compounds To Test

January 13, 1978

In Brief: New San Antonio Center Wins Core Grants; ASCO forming A Technology Assessment Committee

July 19, 1991

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

Growth in Research Capacity Explains Increased Competition, NIH Director Tells NCAB.

June 16, 2006

Lenalidomide Maintenance Increased PFS and Survival

May 25, 2012